Bo Wu

No. 1, Minde Rd
Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Mitral Valve Repair vs. Replacement: Hemodynamics in Valve Surgery.

Mitral Valve Repair vs. Replacement: Hemodynamics in Valve Surgery.

Journal: Reviews in cardiovascular medicine
Published: December 20, 2025

MMT: A Potential Mechanism of Myocardial Fibrosis - Regulation of the TGF-β1/Smad3 Pathway and Prospects for Targeted Therapy.

MMT: A Potential Mechanism of Myocardial Fibrosis - Regulation of the TGF-β1/Smad3 Pathway and Prospects for Targeted Therapy.

Journal: Reviews in cardiovascular medicine
Published: December 16, 2025

Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small cell lung cancer.

Critical timing: Impact of delays to surgery on prognosis in stage I-II non-small cell lung cancer.

Journal: PloS one
Published: October 18, 2024

Machine learning predictive models and risk factors for lymph node metastasis in non-small cell lung cancer.

Machine learning predictive models and risk factors for lymph node metastasis in non-small cell lung cancer.

Journal: BMC pulmonary medicine
Published: November 21, 2023

The influence of different sequences of vessel ligation on long-term survival during video-assisted thoracoscopic lobectomy for non-small cell lung cancer: A matched cohort study.

The influence of different sequences of vessel ligation on long-term survival during video-assisted thoracoscopic lobectomy for non-small cell lung cancer: A matched cohort study.

Journal: Medicine
Published: October 31, 2023

Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.

Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.

Journal: PloS one
Published: October 27, 2023

Prognostic value of lymph node ratio in stage III non-small-cell lung cancer: A retrospective cohort study.

Prognostic value of lymph node ratio in stage III non-small-cell lung cancer: A retrospective cohort study.

Journal: Medicine
Published: October 06, 2023

Prognostic value and immune landscapes of cuproptosis-related lncRNAs in esophageal squamous cell carcinoma.

Prognostic value and immune landscapes of cuproptosis-related lncRNAs in esophageal squamous cell carcinoma.

Journal: Aging
Published: May 18, 2023

Prognostic value and immune landscapes of anoikis-associated lncRNAs in lung adenocarcinoma.

Prognostic value and immune landscapes of anoikis-associated lncRNAs in lung adenocarcinoma.

Journal: Aging
Published: May 09, 2023

Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study.

Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study.

Journal: Medicine
Published: February 23, 2023

Prognostic factors and survival prediction for patients with metastatic lung adenocarcinoma: A population-based study.

Prognostic factors and survival prediction for patients with metastatic lung adenocarcinoma: A population-based study.

Journal: Medicine
Published: January 10, 2023

Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy.

Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy.

Journal: Current pharmaceutical design
Published: July 23, 2022
Showing 1-12 of 14

Last Updated: 09/26/2026